THREE firms are to undergo examination for a £55 million Private Finance Initiative deal to build a major new cancer facility near Hull.
HBG, Jarvis and Shepherd were chosen from a long list of nine firms to bid for the deal to build an oncology and haematology unit at the Castle Hill hospital in Cottingham for Hull and East Yorkshire Hospitals NHS Trust.
Those that missed out were Kajima, Clugston, Gleeson, Impregilo, Morrison and Bilfinger Berger.
The trust is now putting the finishing touches to bid documents which will be sent out later this spring. Tenders will be returned in the autumn and a preferred bidder will be announced by the end of the year. Financial close is due next spring.
The project involves building radiotherapy and chemotherapy treatment wards as well as an outpatient unit and staff accommodation. A linear accelerator must be built on the site to produce radioactive medicines.
One project source said: 'This presents a major construction challenge because it will need a high degree of shielding to prevent dangerous emissions.'
The scheme will take around two years to build and will increase the number of elective surgery facilities available at Castle Hill, allowing the closure of elements of the Princess Royal hospital in Hull.